Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. The encoded enzyme is regulated by steroid hormones. In tissue culture, the enzyme has been found to generate amyloidogenic fragments from the amyloid precursor protein, suggesting a potential for involvement in Alzheimer's disease. Multiple alternatively spliced transcript variants that encode different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008].
Lou, Si, Chen, Sun, Zhang, Niu, Hu: "Correlation between KLK6 expression and the clinicopathological features of glioma." in: Contemporary oncology (Pozna?, Poland), Vol. 18, Issue 4, pp. 246-51, (2014) (PubMed).
Pampalakis, Kurlender, Diamandis, Sotiropoulou: "Cloning and characterization of novel isoforms of the human kallikrein 6 gene." in: Biochemical and biophysical research communications, Vol. 320, Issue 1, pp. 54-61, (2004) (PubMed).
Bayés, Tsetsenis, Ventura, Vendrell, Aviles, Sotiropoulou: "Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation/inactivation." in: Biological chemistry, Vol. 385, Issue 6, pp. 517-24, (2004) (PubMed).
Christophi, Isackson, Blaber, Blaber, Rodriguez, Scarisbrick: "Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating disease." in: Journal of neurochemistry, Vol. 91, Issue 6, pp. 1439-49, (2004) (PubMed).
Iwata, Maruyama, Akagi, Hashikawa, Kanazawa, Tsuji, Nukina: "Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies." in: Human molecular genetics, Vol. 12, Issue 20, pp. 2625-35, (2003) (PubMed).